Watch online 🔒or listen on the go — make "Ask the Experts" your new go-to podcast! Click here to download the audio 🔒

In episode 10, our experts covered your questions on:

• What does the latest research tell us about knee, shoulder, and hip joint denervation?
• What protocol is recommended for identifying and treating pain with knee and other joint denervations?
• Should we consider denervation before or after joint replacement, peripheral stimulation, or orthobiologic therapy in our protocol?
• Which modality provides the most effective image guidance – fluoroscopy or ultrasound – and can or should they be combined?
• Do enhanced lesioning treatments utilizing cooled radiofrequency, bipolar, and or multi-tined radiofrequency probes improve outcomes?
• Is phenol neurolysis comparable to radiofrequency denervation, and if so, what phenol volume and concentration should be used?
• Are hip and shoulder denervation comparable to knee denervation on a risk vs benefit basis?

Your expert panel for this October 10, 2024 webinar included:

• Christine Hunt, DO, MS, of the Mayo Clinic in Jacksonville, Florida, who also serves IPSIS as Vice-Chair of the Evidence Analysis Committee; and
• Ameet Nagpal, MD, MS, MEd, MBA, of the Medical University of South Carolina College of Medicine, who also serves IPSIS as Chair of the Guidelines Committee.

The panel was moderated by Michael Furman, MD, MS, Fellowship Director at OSS Health, who also serves on the IPSIS Board as a Member-at-Large.

Episode 10 Show Notes: These are the abstracts referenced by our experts.

• Anatomical Study of the Innervation of Anterior Knee Joint Capsule: Implication for Image-Guided Intervention
• Cooled Radiofrequency Ablation of the Articular Sensory Branches of the Obturator and Femoral Nerves using Fluoroscopy and Ultrasound Guidance: A Large Retrospective Study
• Genicular nerve radiofrequency ablation for the treatment of chronic knee joint pain: a real-world cohort study with evaluation of prognostic factors
• Radiofrequency ablation of the hip: review
• Shoulder Ablation Approaches
• Terminal Sensory Articular Nerve Radiofrequency Ablation for the Treatment of Chronic Intractable Shoulder Pain: A Novel Technique and Case Series

Watch online 🔒or listen on the go — make "Ask the Experts" your new go-to podcast! Click here to download the audio 🔒

In episode 9, our experts covered your questions on:

• How do you recognize, diagnose, and treat symptomatic hypersensitivity reactions to contrast media?
• How do you prevent repeat hypersensitivity reactions with a proper history?
• How do you discuss pretreatment for patients with known hypersensitivity reactions?
• Which iodinated contrast media should we consider?
• When should gadolinium-based contrast media be considered?
• What are appropriate contrast media concentrations and volumes?
• How should you manage procedures when there are iodinated contrast media shortages?

Your expert panel for this August 6, 2024 webinar included:

• Past President Timothy Maus, MD, a Mayo Clinic Professor Emeritus of Radiology, and moderator of the Case Review Community; and
• Christin A. Tiegs-Heiden, MD, of the Mayo Clinic in Rochester, Minnesota.

The panel was moderated by Michael Furman, MD, MS, Fellowship Director at OSS Health, who also serves on the IPSIS Board as a Member-at-Large.

Episode 9 Show Notes: These are the abstracts referenced by our experts.

• The American College of Radiology Manual on Contrast Media
• The Use of Contrast Agents in Interventional Pain Procedures: A Multispecialty and Multisociety Practice Advisory on Nephrogenic Systemic Fibrosis, Gadolinium Deposition in the Brain, Encephalopathy After Unintentional Intrathecal Gadolinium Injection, and Hypersensitivity Reactions

Watch online 🔒or listen on the go — make "Ask the Experts" your new go-to podcast! Click here to download the audio 🔒

In episode 8, our experts covered your questions on:

• What history and exam findings suggest a vertebrogenic pain source?
• What imaging and diagnostic tests can identify or rule out a vertebrogenic pain source?
• Is it appropriate to make vertebrogenic treatment decisions based solely on imaging findings?
• Should other pain sources be considered/ruled out before treating vertebrogenic pain?
• What procedures are indicated with Modic changes at L2/3?
• What procedures are indicated in the setting of lumbar scoliosis and Modic changes?
• How do you select patients when MRIs demonstrate multiple spinal pathologies and Modic changes?
• How do you use MRIs for pre-op planning?
• This is a technically challenging procedure. Any intra-procedure pearls?

Your expert panel for this June 4, 2024 webinar included:

• Ryan Reeves, MD, of Spine Team Texas in Southlake, Texas; and
• Past President Matthew Smuck, MD, of Stanford University in Redwood City, California.

The panel was moderated by Michael Furman, MD, MS, Fellowship Director at OSS Health, who also serves on the IPSIS Board as a Member-at-Large.

Watch online 🔒 or listen on the go — make "Ask the Experts" your new go-to podcast! Click here to download the audio 🔒.

In episode 7, our experts covered your questions on:

• What history and exam findings suggest a discal pain source?
• What imaging and diagnostic tests can identify or rule out a discal pain source?
• Does the presence and/or type of Modic endplate changes affect your treatment of discogenic lower back pain?
• Is it appropriate to make intradiscal treatment decisions based solely on imaging findings and clinical scenarios?
• When performing intradiscal treatments, what injectate options are there?
• Should prophylactic antibiotics be administered prior to intradiscal procedures? Which ones?
• What is the optimal volume for intradiscal injectate?
  

Your expert panel for this April 25, 2024 webinar included:

• IPSIS Master Instructor, Aaron Calodney, MD;
• Past President and Founding Member, Richard Derby, MD; and
• IPSIS Membership Committee Chair, Scott Naftulin, DO
  

The panel was moderated by Michael Furman, MD, MS, Fellowship Director at OSS Health, who also serves on the IPSIS Board as a Member-at-Large.

Episode 7 Show Notes: These are the abstracts referenced by our experts.

• Autologous Bone Marrow Concentrate Intradiscal Injection for the Treatment of Degenerative Disc Disease with Three-Year Follow-up
• Bone Marrow Concentrate and Platelet‐Rich Plasma Differ in Cell Distribution and Interleukin 1 Receptor Antagonist Protein Concentration
• Case Series of Ultrasound-Guided Platelet-Rich Plasma Injections for Sacroiliac Joint Dysfunction
• Clinical Outcomes Following Intradiscal Injections of Higher‐Concentration Platelet‐Rich Plasma in Patients with Chronic Lumbar Discogenic Pain
• Effectiveness of Intradiscal Platelet Rich Plasma for Discogenic Low Back Pain Without Modic Changes: A Randomized Controlled Trial
• Effect of Age on Outcomes After Allogeneic Disc Tissue Supplementation in Patients with Chronic Discogenic Low Back Pain in the VAST Trial
• Evaluation of the Effectiveness of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Chronic Low Back Pain Due to Severe Lumbar Spinal Degeneration: A 12-Month, Open-Label, Prospective Controlled Trial
• Increased Expression of Inflammatory Cytokines and Discogenic Neck Pain
• Injections of Concentrated Bone Marrow Aspirate as Treatment for Discogenic Pain: a Retrospective Analysis
• Insights into Exosome in the Intervertebral Disc: Emerging Role for Disc Homeostasis and Normal Function
• Intradiscal Platelet-Rich Plasma Injection for Discogenic Low Back Pain and Correlation with Platelet Concentration: A Prospective Clinical Trial
• Mesenchymal Stem Cells: Environmentally Responsive Therapeutics for Regenerative Medicine
• Platelet-Rich Plasma-Releasate (PRPr) for the Treatment of Discogenic Low Back Pain Patients: Long-Term Follow-Up Survey
• Potential Role for Stem Cell Regenerative Therapy as a Treatment for Degenerative Disc Disease and Low Back Pain: A Systematic Review
• Preclinical Animal Study and Pilot Clinical Trial of Using Enriched Peripheral Blood-Derived Mononuclear Cells for Intervertebral Disc Degeneration
• Regulatory Roles of Noncoding RNAs in Intervertebral Disc Degeneration as Potential Therapeutic Targets (Review)
• Risks of Intradiscal Orthobiologic Injections: A Review of the Literature and Case Series Presentation
• Safety and Efficacy of Platelet Rich Plasma for Treatment of Lumbar Discogenic Pain: A Prospective, Multicenter, Randomized, Double-blind Study
• Single-Cell Transcriptome Profiling Reveals Multicellular Ecosystem of Nucleus Pulposus during Degeneration Progression
• Stem Cells and Discogenic Back Pain
• Stem Cells and Exosomes: New Therapies for Intervertebral Disc Degeneration
• Structural Organization of the Bone Marrow and its Role in Hematopoiesis
• Systematic Review of Platelet-Rich Plasma for Low Back Pain
• Technical Considerations in Obtaining Platelet Rich Fibrin for Clinical and Periodontal Research
• The Analgesic Efficacy of Intradiscal Injection of Bone Marrow Aspirate Concentrate and Culture-Expanded Bone Marrow Mesenchymal Stromal Cells in Discogenic Pain: A Systematic Review
• The Effect of Intradiscal Platelet-Rich Plasma Injection for Management of Discogenic Lower Back Pain: A Meta-Analysis
• The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up
• VAST Clinical Trial: Safely Supplementing Tissue Lost to Degenerative Disc Disease
  
  

Watch online 🔒 or listen on the go — make "Ask the Experts" your new go-to podcast! Click here to download the audio 🔒.

In episode 6, our experts covered your questions on:

• Which "red flag" symptoms warrant imaging?
• Other than trauma and "red flags," when else do we need imaging, and what should we get?
• When MRI isn’t an option, when is a myelogram preferred over a "dry” CT?
• Can bone scans assist in diagnosing facet-mediated and /or other types of pain?
• How are modic changes associated with low back pain?
• When are interventional pain physicians responsible for incidental findings?
• What are the latest recommendations about gadolinium?
  

Your expert panel for this February 8, 2024 webinar included:

• Felix E. Diehn, MD, Consultant and Associate Professor in Radiology at Mayo Clinic in Rochester, Minnesota; and
• IPSIS Secretary, Vinil Shah, MD, Associate Professor of Radiology and Chief of the Neuroradiology Division at the University of California San Francisco (UCSF).
  

The panel was moderated by Michael Furman, MD, MS, Fellowship Director at OSS Health, who also serves on the IPSIS Board as a Member-at-Large.

Watch online 🔒 or listen on the go — make "Ask the Experts" your new go-to podcast! Click here to download the audio 🔒.

In episode 5, our experts covered topics not addressed in the prior Peri-procedural Considerations webinar, regarding pre-, intra-, and post-procedure patient care, and provided specific:

• Tactics to Help Treat Patients with Contrast Media Allergies
• Tips on Addressing Radiofrequency Neurotomy Challenges Posed by Patients with Pacemakers, Defibrillators, and Other Implanted Hardware
  
• Selection Strategies for Injectate Composition and Volume
  

Your expert panel for this December 5, 2023 webinar included:

• IPSIS Treasurer, Zachary L. McCormick, MD, Vice Chair and Associate Professor in the Department of Physical Medicine and Rehabilitation (PM&R) at the University of Utah; and
• IPSIS Research Division Chair, W. Evan Rivers, DO, a physiatrist at the VA Tennessee Valley Healthcare System.
  

The panel was moderated by Michael Furman, MD, MS, Fellowship Director at OSS Health, who also serves on the IPSIS Board as a Member-at-Large.

Watch online 🔒 or listen on the go — make "Ask the Experts" your new go-to podcast! Click here to download the audio 🔒.

In episode 4, our experts covered your questions on::

• Tactics to Navigate Medicare/Medicaid and Avoid Recoupment and Penalties
  
• Tips on Avoiding Peer-to-Peer Reviews — Regardless of Region
  
• Approaches for Medicare and Private Payer Prior Authorization
  
• Information on Local Coverage Determinations (LCDs) and UCR (Usual, Customary, and Reasonable) Rates
  
• Strategies to Document and Schedule ESIs, Facet and SIJ Interventions
  
• Methods to Utilize Advance Beneficiary Notices (ABNs) of Non-Coverage to Get Paid for Services Not Usually Covered by Medicare
  

Your expert panel for this October 23, 2023 webinar included:

• D. Scott Kreiner, MD,  a physiatrist and interventional spine specialist at Barrow Neurological Institute; and
• Richard W. Rosenquist, MD, Chairman of the Department of Pain Management in the Anesthesiology Institute of the Cleveland Clinic.

The panel was moderated by Michael Furman, MD, MS, Fellowship Director at OSS Health.

Watch online 🔒 or listen on the go — make "Ask the Experts" your new go-to podcast! Click here to download the audio 🔒.

In episode 3, our experts covered your questions on:

• What are the thrombotic implications of stopping ACAP medications?
  
• Which procedures can be safely performed without stopping ACAP medications?
  
• If stopped, are some ACAP medications more likely to result in thrombotic events?
  
• What are the incidence and implications of bleeding complications during procedures, and are these risks increased when ACAP medications are continued?
  
• Why should interventionists be more involved in ACAP medication decisions instead of reflexively deferring to the prescribing physician?
  

Your expert panel for this August 15, 2023 webinar included:

• Byron J. Schneider, MD, Director of the Interventional Spine and Musculoskeletal Medicine Fellowship at Vanderbilt University Medical Center; and
• Gene Tekmyster, DO, Assistant Professor of Clinical Orthopaedic Surgery at Keck Hospital of USC.
  

The panel was moderated by Michael B. Furman, MD, MS, Fellowship Director at OSS Health.

Watch online 🔒 or listen on the go — make "Ask the Experts" your new go-to podcast!  Click here to download the audio 🔒.

In episode 2, our experts covered your questions on:

• What's the right amount and frequency?
  
• What's the daily and lifetime maximum?
  
• Why do some regenerative medicine physicians consider steroids "poison”?
• Are non-particulate steroids really non-inferior?

Your expert panel for this July 18, 2023 webinar included:

• Kate Sayeed, MD, Director of Pain Medicine at the VA Texas Valley Coastal Bend Healthcare System; and
• Alison Stout, DO, of the Cleveland Clinic, Lerner College of Medicine.

The panel was moderated by Michael B. Furman, MD, MS, Fellowship Director at OSS Health.

Watch online 🔒 or listen on the go — make "Ask the Experts" your new go-to podcast!  Click here to download the audio 🔒.

In episode 1, our experts covered your questions on:

• Managing Contrast Allergies and the Necessity of Contrast
  
• Injectate Volumes / Test Doses
  
• Post-Procedure Driving
  
• Infections / Antibiotics
  
• Vital Sign Cutoffs
  
• Pre-Procedure Imaging Time Frames
  
• Monitored Anesthesia Care / Sedation / Putting Patients at Ease
  

Your expert panel for this June 13, 2023 webinar included:

• David J. "D.J." Kennedy, MD, Professor, and Chair of Physical Medicine and Rehabilitation at Vanderbilt University Medical Center; and
• Joshua Rittenberg, MD, Clinical Associate Professor in the Department of Orthopaedic Surgery at Stanford University.

The panel was moderated by Michael B. Furman, MD, MS, Fellowship Director at OSS Health.